Gillibrand calls on DEA to relist marijuana as a Schedule III substance
Medical Marijuana Program Connection
NOVEMBER 26, 2023
Kirsten Gillibrand has asked the U.S. Drug Enforcement Agency (DEA) to reschedule marijuana from a Schedule I to a Schedule III substance. Read More
Let's personalize your content